Irene Barguilla, Veronique Maguer-Satta, Boris Guyot, Susana Pastor, Ricard Marcos, et al.. In Vitro Approaches to Determine the Potential Carcinogenic Risk of Environmental Pollutants. International Journal of Molecular Sciences, 2023, 24, ⟨10.3390/ijms24097851⟩. ⟨hal-04159786⟩

Boris Guyot, Flora Clément, Youenn Drouet, Xenia Schmidt, Sylvain Lefort, et al.. An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers. Cancer Research Communications, 2023, 3 (9), pp.1966-1980. ⟨10.1158/2767-9764.CRC-23-0196⟩. ⟨hal-04237719⟩

Christelle Granier, Johan Toesca, Chloé Mialon, Maureen Ritter, Natalia Freitas, et al.. Low-density hepatitis C virus infectious particles are protected from oxidation by secreted cellular proteins. mBio, In press, ⟨10.1128/mbio.01549-23⟩. ⟨hal-04237101⟩

Alexandra Mougel, Eric Adriaenssens, Boris Guyot, Lu Tian, Stéphanie Gobert, et al.. Macrophage-Colony-Stimulating Factor Receptor Enhances Prostate Cancer Cell Growth and Aggressiveness In Vitro and In Vivo and Increases Osteopontin Expression. International Journal of Molecular Sciences, 2022, 23, ⟨10.3390/ijms232416028⟩. ⟨hal-04237745⟩

Vincent Alcazer, Paola Bonaventura, Laurie Tonon, Emilie Michel, Virginie Mutez, et al.. HERVs characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapy. American Journal of Hematology, 2022, 97 (9), pp.1200-1214. ⟨10.1002/ajh.26647⟩. ⟨hal-03855460⟩

Rahul Kumar, Raquel Pereira, Julian Niemann, Alexander Azimpour, Costanza Zanetti, et al.. The differential role of the lipid raft-associated protein flotillin 2 for progression of myeloid leukemia. Blood Advances, 2022, 6 (12), pp.3611-3624. ⟨10.1182/bloodadvances.2021005992⟩. ⟨hal-03758727⟩